tiprankstipranks
OncoCyte Corp (OCX)
NASDAQ:OCX
Holding OCX?
Track your performance easily

OncoCyte (OCX) Technical Analysis

410 Followers

Technical Sentiment

Overall Consensus
Sell
7Bullish
3Neutral
12Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
OncoCyte Corp’s (OCX) Moving Averages Convergence Divergence (MACD) indicator is -0.10, suggesting OncoCyte Corp is a Buy.
OncoCyte Corp’s (OCX) 20-Day exponential moving average is 2.85, while OncoCyte Corp’s (OCX) share price is $2.67, making it a Sell.
OncoCyte Corp’s (OCX) 50-Day exponential moving average is 2.95, while OncoCyte Corp’s (OCX) share price is $2.67, making it a Sell.

OncoCyte (OCX) Pivot Points

Nov 22, 2024, 02:22 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.23
2.38
2.46
2.61
2.70
2.85
2.93
Fibonacci
2.38
2.47
2.52
2.61
2.70
2.76
2.85
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

OncoCyte (OCX) Moving Averages

Nov 22, 2024, 02:22 AM
Period
Simple
Exponential
MA5
2.67Buy
2.70Buy
MA10
2.79Sell
2.77Sell
MA20
2.89Sell
2.85Sell
MA50
2.99Sell
2.95Sell
MA100
3.06Sell
2.99Sell
MA200
2.95Sell
3.00Sell
OncoCyte Corp’s (OCX) 10-Day exponential moving average is 2.77, while OncoCyte Corp’s (OCX) share price is $2.67, making it a Sell.
OncoCyte Corp’s (OCX) 100-Day exponential moving average is 2.99, while OncoCyte Corp’s (OCX) share price is $2.67, making it a Sell.
OncoCyte Corp’s (OCX) stock price is $2.67 and OncoCyte Corp’s (OCX) 50-day simple moving average is 2.99, creating a Sell signal.
OncoCyte Corp’s (OCX) stock price is $2.67 and OncoCyte Corp’s (OCX) 100-day simple moving average is 3.06, creating a Sell signal.
OncoCyte Corp’s (OCX) stock price is $2.67 and OncoCyte Corp’s (OCX) 200-day simple moving average is 2.95, creating a Sell signal.

OncoCyte (OCX) Technical Indicators

Nov 22, 2024, 02:22 AM
Name
Value
Implied Action
RSI (14)
42.68
Neutral
STOCH (9,6)
19.32
Buy
STOCHRSI (14)
19.05
Buy
MACD (12,26)
-0.10
Buy
ADX (14)
27.48
Neutral
Williams %R
-53.70
Buy
CCI (14)
-118.98
Buy
ATR (14)
0.17
-
Ultimate Oscillator
47.02
Neutral
ROC
-9.24
Sell
OncoCyte Corp’s (OCX) Relative Strength Index (RSI) is 42.68, creating a Neutral signal.
OncoCyte Corp’s (OCX) Trend Strength Indicator (ADX) is 27.48, creating a Neutral signal.
OncoCyte Corp’s (OCX) Commodity Channel Index (CCI) is -118.98, creating a Buy signal.
OncoCyte Corp’s (OCX) Price Rate of Change (ROC) is -9.24, creating a Sell signal.

FAQ

Is OCX a Buy, Hold, or Sell?
Based on OCX’s technical indicators, OCX is a Sell.
    What is OCX’s RSI (14)?
    OCX’s RSI (14) is 42.68, which suggests OCX is a Neutral.
      What is OCX’s MACD?
      OCX’s MACD is -0.10, which suggests OCX is a Buy.
        What is OCX’s 5-day moving average?
        OCX’s 5-day moving average is 2.67, which suggests OCX is a Buy.
          What is OCX’s 20-day moving average?
          OCX 20-day moving average is 2.89, which suggests OCX is a Sell.
            What is OCX’s 50-day moving average?
            OCX’s 50-day moving average is 2.99, which suggests OCX is a Sell.
              What is OCX’s 200-day moving average?
              OCX’s 200-day moving average is 2.95, which suggests OCX is a Sell.
                What is OCX’s Williams % R (14)?
                OCX’s Williams % R (14) is -53.70, which suggests OCX is a Buy.
                  What is OCX’s CCI (14)?
                  OCX’s CCI (14) is -118.98, which suggests OCX is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis